Published in PLoS Pathog on August 29, 2013
Potential of selected Senegalese Aedes spp. mosquitoes (Diptera: Culicidae) to transmit Zika virus. BMC Infect Dis (2015) 1.23
Tracking Dengue Virus Intra-host Genetic Diversity during Human-to-Mosquito Transmission. PLoS Negl Trop Dis (2015) 1.10
Whole-Genome Sequencing Analysis from the Chikungunya Virus Caribbean Outbreak Reveals Novel Evolutionary Genomic Elements. PLoS Negl Trop Dis (2016) 0.96
Alphavirus RNA synthesis and non-structural protein functions. J Gen Virol (2015) 0.96
Dengue virus RNA structure specialization facilitates host adaptation. PLoS Pathog (2015) 0.95
Complete genome sequences of two middelburg viruses isolated from arthropods in the central african republic. Genome Announc (2014) 0.85
Comprehensive Genome Scale Phylogenetic Study Provides New Insights on the Global Expansion of Chikungunya Virus. J Virol (2016) 0.85
Comparative analysis of viral RNA signatures on different RIG-I-like receptors. Elife (2016) 0.80
Standing your ground to exoribonucleases: Function of Flavivirus long non-coding RNAs. Virus Res (2015) 0.78
The 5' and 3' ends of alphavirus RNAs--Non-coding is not non-functional. Virus Res (2015) 0.77
A Viral mRNA Motif at the 3'-Untranslated Region that Confers Translatability in a Cell-Specific Manner. Implications for Virus Evolution. Sci Rep (2016) 0.77
Genetic Drift, Purifying Selection and Vector Genotype Shape Dengue Virus Intra-host Genetic Diversity in Mosquitoes. PLoS Genet (2016) 0.76
Unusual pattern of chikungunya virus epidemic in the Americas, the Panamanian experience. PLoS Negl Trop Dis (2017) 0.75
Dynamics of molecular evolution in RNA virus populations depend on sudden versus gradual environmental change. Evolution (2017) 0.75
Complete Genome Sequences of Two Chikungunya Viruses Isolated in the Central African Republic in the 1970s and 1980s. Genome Announc (2017) 0.75
MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE. J Virol (2017) 0.75
MODELTEST: testing the model of DNA substitution. Bioinformatics (1998) 101.19
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog (2007) 10.38
Secondary structure prediction for aligned RNA sequences. J Mol Biol (2002) 8.80
Multiple alignment of DNA sequences with MAFFT. Methods Mol Biol (2009) 7.59
Chikungunya: a re-emerging virus. Lancet (2011) 3.73
Essential role of cyclization sequences in flavivirus RNA replication. J Virol (2001) 3.31
RNAalifold: improved consensus structure prediction for RNA alignments. BMC Bioinformatics (2008) 3.29
Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol (2010) 3.18
A single positively selected West Nile viral mutation confers increased virogenesis in American crows. Nat Genet (2007) 3.02
A highly structured, nuclease-resistant, noncoding RNA produced by flaviviruses is required for pathogenicity. Cell Host Microbe (2008) 2.93
Malaria and the work of WHO. Bull World Health Organ (1989) 2.45
Mutagenesis of the 3' nontranslated region of Sindbis virus RNA. J Virol (1990) 2.42
Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies. Vector Borne Zoonotic Dis (2006) 2.37
A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication. J Gen Virol (2003) 2.25
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
Sylvatic transmission of arboviruses among Bornean orangutans. Am J Trop Med Hyg (2001) 2.02
The 3'-non-coding regions of alphavirus RNAs contain repeating sequences. J Mol Biol (1982) 1.92
A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes. Am J Trop Med Hyg (2001) 1.85
Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore. J Gen Virol (2009) 1.85
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
An animal model for studying the pathogenesis of chikungunya virus infection. Am J Trop Med Hyg (2008) 1.83
Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission. Future Microbiol (2011) 1.72
An APL-programmed genetic algorithm for the prediction of RNA secondary structure. J Theor Biol (1995) 1.72
Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells. J Virol (2012) 1.58
RNA structures required for production of subgenomic flavivirus RNA. J Virol (2010) 1.52
An RNA pseudoknot is required for production of yellow fever virus subgenomic RNA by the host nuclease XRN1. J Virol (2010) 1.49
PseudoViewer3: generating planar drawings of large-scale RNA structures with pseudoknots. Bioinformatics (2009) 1.45
West Nile virus encodes a microRNA-like small RNA in the 3' untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells. Nucleic Acids Res (2011) 1.44
Comparison of two aquatic alphaviruses, salmon pancreas disease virus and sleeping disease virus, by using genome sequence analysis, monoclonal reactivity, and cross-infection. J Virol (2002) 1.41
West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. J Virol (2012) 1.35
Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J Virol (1992) 1.34
A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. RNA (2012) 1.32
Multiple binding sites for cellular proteins in the 3' end of Sindbis alphavirus minus-sense RNA. J Virol (1993) 1.32
Every microsatellite is different: Intrinsic DNA features dictate mutagenesis of common microsatellites present in the human genome. Mol Carcinog (2009) 1.29
Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol (1997) 1.28
Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells. Cell Host Microbe (2010) 1.22
Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res (1999) 1.22
Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication. Proc Natl Acad Sci U S A (2012) 1.20
The alphavirus 3'-nontranslated region: size heterogeneity and arrangement of repeated sequence elements. Virology (1998) 1.19
The 3' untranslated region of sindbis virus represses deadenylation of viral transcripts in mosquito and Mammalian cells. J Virol (2007) 1.18
History of Aedes aegypti eradication in the Americas. Bull World Health Organ (1967) 1.16
Origin and evolution of 3'UTR of flaviviruses: long direct repeats as a basis for the formation of secondary structures and their significance for virus transmission. Adv Virus Res (2007) 1.09
Requirements at the 3' end of the sindbis virus genome for efficient synthesis of minus-strand RNA. J Virol (2005) 1.07
Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus. J Virol (2005) 1.06
Identification of viral microRNAs. Methods Enzymol (2007) 1.04
Direct repeats in the 3' untranslated regions of mosquito-borne flaviviruses: possible implications for virus transmission. J Gen Virol (2006) 0.96
Origin and evolution of flavivirus 5'UTRs and panhandles: trans-terminal duplications? Virology (2007) 0.95
Functional interaction between cellular p100 and the dengue virus 3' UTR. J Gen Virol (2010) 0.93
Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm. J Biol Chem (2012) 0.93
The 3' untranslated regions of Kamiti River virus and Cell fusing agent virus originated by self-duplication. J Gen Virol (2006) 0.91
Alphavirus RNA genome repair and evolution: molecular characterization of infectious sindbis virus isolates lacking a known conserved motif at the 3' end of the genome. J Virol (2000) 0.90
The 3' untranslated region of tick-borne flaviviruses originated by the duplication of long repeat sequences within the open reading frame. Virology (2006) 0.90
Small noncoding RNA modulates Japanese encephalitis virus replication and translation in trans. Virol J (2011) 0.86
Characterization of untranslated regions of the salmonid alphavirus 3 (SAV3) genome and construction of a SAV3 based replicon. Virol J (2009) 0.85
Personal experiences in the malaria eradication campaign 1955-1962. J R Soc Med (2002) 0.77
Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage. PLoS Negl Trop Dis (2012) 5.31
Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med (2015) 5.16
Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol (2010) 3.18
West Nile virus in Mexico: evidence of widespread circulation since July 2002. Emerg Infect Dis (2003) 2.27
Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One (2009) 2.22
Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A (2011) 2.12
Venezuelan encephalitis emergence mediated by a phylogenetically predicted viral mutation. Proc Natl Acad Sci U S A (2006) 2.07
The history and evolution of human dengue emergence. Adv Virus Res (2008) 2.05
Arbovirus evolution in vivo is constrained by host alternation. Proc Natl Acad Sci U S A (2008) 2.04
Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog (2011) 1.95
Venezuelan equine encephalitis emergence: enhanced vector infection from a single amino acid substitution in the envelope glycoprotein. Proc Natl Acad Sci U S A (2004) 1.95
Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol (2011) 1.86
Chimeric alphavirus vaccine candidates for chikungunya. Vaccine (2008) 1.78
4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J (2011) 1.77
Genome sequence and attenuating mutations in West Nile virus isolate from Mexico. Emerg Infect Dis (2004) 1.73
Negevirus: a proposed new taxon of insect-specific viruses with wide geographic distribution. J Virol (2012) 1.67
Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription. J Virol (2007) 1.64
Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog (2011) 1.62
Introductions of West Nile virus strains to Mexico. Emerg Infect Dis (2006) 1.61
Molecular epidemiology of group C viruses (Bunyaviridae, Orthobunyavirus) isolated in the Americas. J Virol (2005) 1.60
Chimeric Sindbis/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice. Vaccine (2007) 1.58
Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol (2011) 1.57
Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential. Proc Natl Acad Sci U S A (2011) 1.57
Effect of alternating passage on adaptation of sindbis virus to vertebrate and invertebrate cells. J Virol (2005) 1.57
Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells. PLoS Pathog (2009) 1.56
Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J Virol (2003) 1.54
Evolutionary processes among sylvatic dengue type 2 viruses. J Virol (2007) 1.54
Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J Virol (2005) 1.53
Direct broad-range detection of alphaviruses in mosquito extracts. Virology (2007) 1.52
Transmission of a Venezuelan equine encephalitis complex Alphavirus by Culex (Melanoconion) gnomatos (Diptera: Culicidae) in northeastern Peru. J Med Entomol (2005) 1.52
Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad. Virology (2009) 1.51
Dengue emergence and adaptation to peridomestic mosquitoes. Emerg Infect Dis (2004) 1.50
Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg Infect Dis (2008) 1.49
Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology (2006) 1.49
Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus. J Virol (2002) 1.49
Endemic Venezuelan equine encephalitis in northern Peru. Emerg Infect Dis (2004) 1.47
Evolutionary patterns of eastern equine encephalitis virus in North versus South America suggest ecological differences and taxonomic revision. J Virol (2009) 1.45
Evaluation of methods to assess transmission potential of Venezuelan equine encephalitis virus by mosquitoes and estimation of mosquito saliva titers. Am J Trop Med Hyg (2005) 1.44
Venezuelan equine encephalitis virus in the mosquito vector Aedes taeniorhynchus: infection initiated by a small number of susceptible epithelial cells and a population bottleneck. Virology (2007) 1.39
Endemic eastern equine encephalitis in the Amazon region of Peru. Am J Trop Med Hyg (2007) 1.38
Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence. J Virol (2008) 1.36
Potential role of sylvatic and domestic African mosquito species in dengue emergence. Am J Trop Med Hyg (2005) 1.36
Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J Virol (2007) 1.35
Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. J Virol (2002) 1.33
Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission. Am J Trop Med Hyg (2006) 1.33
Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol (2012) 1.31
Landscape ecology of sylvatic chikungunya virus and mosquito vectors in southeastern Senegal. PLoS Negl Trop Dis (2012) 1.28
Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. J Virol (2006) 1.26
Characterization of a novel Negevirus and a novel Bunyavirus isolated from Culex (Culex) declarator mosquitoes in Trinidad. J Gen Virol (2013) 1.26
Serologic evidence of arboviral infections among humans in Kenya. Am J Trop Med Hyg (2011) 1.23
Anopheles gambiae heat shock protein cognate 70B impedes o'nyong-nyong virus replication. BMC Genomics (2007) 1.20
Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication. Proc Natl Acad Sci U S A (2012) 1.20
IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells. Virology (2008) 1.20
A proposal to change existing virus species names to non-Latinized binomials. Arch Virol (2010) 1.18
Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling. Vaccine (2011) 1.17
Vector-borne transmission imposes a severe bottleneck on an RNA virus population. PLoS Pathog (2012) 1.16
The hamster as an animal model for eastern equine encephalitis--and its use in studies of virus entrance into the brain. J Infect Dis (2004) 1.16
Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology (2007) 1.16
Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgut. J Gen Virol (2006) 1.16
Zika Virus: Diagnosis, Therapeutics, and Vaccine. ACS Infect Dis (2016) 1.15
Identification of dengue fever cases in Houston, Texas, with evidence of autochthonous transmission between 2003 and 2005. Vector Borne Zoonotic Dis (2013) 1.14
Venezuelan equine encephalitis virus transmission and effect on pathogenesis. Emerg Infect Dis (2006) 1.14
Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic venezuelan equine encephalitis virus. J Virol (2005) 1.13
Short report: serological evidence of West Nile virus activity in El Salvador. Am J Trop Med Hyg (2005) 1.13
Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella. Future Virol (2011) 1.12
Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J Clin Microbiol (2004) 1.11
Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol (2013) 1.11
Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol (2008) 1.10
Yellow fever virus maintenance in Trinidad and its dispersal throughout the Americas. J Virol (2010) 1.09
Venezuelan equine encephalitis in Panama: fatal endemic disease and genetic diversity of etiologic viral strains. PLoS Negl Trop Dis (2009) 1.07
Eastern equine encephalitis in Latin America. N Engl J Med (2013) 1.05
Natural enzootic vectors of Venezuelan equine encephalitis virus, Magdalena Valley, Colombia. Emerg Infect Dis (2003) 1.05
Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. J Virol (2005) 1.04
Genetic and phenotypic characterization of sylvatic dengue virus type 2 strains. Virology (2008) 1.04
Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine. Vaccine (2012) 1.03
Vaccines for Venezuelan equine encephalitis. Vaccine (2009) 1.03
Venezuelan equine encephalitis virus, southern Mexico. Emerg Infect Dis (2004) 1.03
Structure of the recombinant alphavirus Western equine encephalitis virus revealed by cryoelectron microscopy. J Virol (2010) 1.03
Western Equine Encephalitis submergence: lack of evidence for a decline in virus virulence. Virology (2008) 1.01
Antigenic relationships between sylvatic and endemic dengue viruses. Am J Trop Med Hyg (2008) 1.01
Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response. J Virol (2011) 1.01
Experimental Everglades virus infection of cotton rats (Sigmodon hispidus). Emerg Infect Dis (2004) 1.00
Experimental infection of Aedes sollicitans and Aedes taeniorhynchus with two chimeric Sindbis/Eastern equine encephalitis virus vaccine candidates. Am J Trop Med Hyg (2008) 1.00
Deforestation alters phytotelm habitat availability and mosquito production in the Peruvian Amazon. Ecol Appl (2006) 0.99
Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol (2013) 0.99
Susceptibility of Ochlerotatus taeniorhynchus (Diptera: Culicidae) to infection with epizootic (subtype IC) and enzootic (subtype ID) Venezuelan equine encephalitis viruses: evidence for epizootic strain adaptation. J Med Entomol (2004) 0.99
Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model. Vaccine (2013) 0.99
IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice. Virology (2013) 0.99